【乳癌基因】《23andMe》旗下「BRCA1/BRCA2」遺傳與癌症風險評估報告，獲得FDA 510(k)與PCCP許可
文章出處
ASCO
原文標題
23andMe Granted FDA 510(k) Clearance to Report Additional BRCA Variants
Twitter
https://twitter.com/aimedadviser/status/1699226161975640396
文章序號
4237
智醫科學－AI醫療技術、應用與市場動態
Copyright
©2023 智醫科學 MEDai.tw
All rights reserved.
The content of
this site is intended for healthcare and medical professionals.
